These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
215 related items for PubMed ID: 7725525
1. Comparative study of two protocols for living-related renal transplantation: donor-specific transfusion versus cyclosporine. Mazzali M, Alves Filho G, Alves MA, de Faria JB. Transplant Proc; 1995 Apr; 27(2):1832-3. PubMed ID: 7725525 [No Abstract] [Full Text] [Related]
2. Donor-specific transfusion for kidney transplantation in the cyclosporine era. Inoue S, Aikawa M, Dobashi Y, Kuzuhara K, Yanagisawa T, Ootubo O, Mimura N. Transplant Proc; 1996 Jun; 28(3):1220-1. PubMed ID: 8658633 [No Abstract] [Full Text] [Related]
3. Donor-specific transfusion in living related and unrelated donor kidney transplantation: minimal sensitization and excellent graft outcome. Kong JM, Jeong JH, Kang JK, Seong IG, Kim BC. Transplant Proc; 1995 Feb; 27(1):1036-7. PubMed ID: 7878792 [No Abstract] [Full Text] [Related]
4. Different trends in immunosuppression: 10 years' experience with cyclosporine after living related donor renal transplantation. Bakr MA, Sally S, Foda MA, Sobh MA, el-Sherif AK, Ghoneim MA. Transplant Proc; 1994 Dec; 26(6):3163-6. PubMed ID: 7998104 [No Abstract] [Full Text] [Related]
5. Single pretransplant donor-specific transfusion in cadaver and living related donor renal transplantation. Alexander JW, Davies CB, First MR, Cofer BR, Munda R, Madden RL, Hariharan S, Schroeder TJ. Transplant Proc; 1993 Feb; 25(1 Pt 1):485-7. PubMed ID: 8438389 [No Abstract] [Full Text] [Related]
9. Effect of flow cytometry, complement-dependent cytotoxicity, and auto cross match on cadaveric renal transplant outcome. Christiaans M, Van den Berg-Loonen E, Ten Haaft A, Nieman F, Van Hooff J. Transplant Proc; 1995 Feb; 27(1):1028-30. PubMed ID: 7878788 [No Abstract] [Full Text] [Related]
10. Comparison between donor-specific transfusions with conventional immunosuppression and triple therapy including cyclosporine in living related donor kidney transplantation. Arbelaez M, Mejia G, Henao JE, Garcia A, Arango JL, Velasquez A, Restrepo J, Garcia LF. Transplant Proc; 1992 Dec; 24(6):3096-7. PubMed ID: 1466072 [No Abstract] [Full Text] [Related]
11. Living related donor renal transplantation in Semarang, Indonesia (1985 to 1991). Shofa C, Soewito A, Darmono E, Hendro W, Lysiani S, Purwanto, Chandra M, Faik H, Rifki M, Parsudi AI. Transplant Proc; 1992 Oct; 24(5):1813. PubMed ID: 1412858 [No Abstract] [Full Text] [Related]
14. Effect of cyclosporine A on the outcome of one-haplotype identical kidney grafts from a living related donor. Papadimitriou M, Vakianis P, Malliara M, Economidou D, Alexopoulos E, Belechri AM, Koukoudis P, Papadopoulou D, Syrganis C, Polymenidis Z. Transplant Proc; 1994 Oct; 26(5):2548-9. PubMed ID: 7940786 [No Abstract] [Full Text] [Related]
15. Living related donor kidney transplantation at a Turkish center. Hamaloğlu E, Tokyay R, Arslan G, Bilgin N, Büyükpamukçu N, Haberal M. Transplant Proc; 1992 Oct; 24(5):1848-9. PubMed ID: 1412878 [No Abstract] [Full Text] [Related]
18. Related donor kidney transplantation is the best form of treatment for uremia. Groth CG, Fehrman I, Ringdén O, Lundgren G. Transplant Proc; 1987 Feb; 19(1 Pt 3):2278-9. PubMed ID: 2978893 [No Abstract] [Full Text] [Related]
20. Donor specific blood transfusions do not improve graft survival in living related donor transplantation. Garcia VD, Kraemer ES, Prompt CA, Santos A, Caovila J, Duarte A, Filho AN, Goldani JC. Transplant Proc; 1987 Feb; 19(1 Pt 3):2271-3. PubMed ID: 3274507 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]